Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

What’s Going On With GSI Technology Today?

GSI Technology, Inc. (NASDAQ: GSIT) shares are trading higher by 145.73% to $4.03 Friday afternoon, despite a lack of company-specific news. The stock is rising on heavy volume as it trends across social media platforms during Friday's session.
byHenry Khederian
May 12, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

GSI Technology, Inc. (NASDAQ:GSIT) shares are trading higher by 145.73% to $4.03 Friday afternoon, despite a lack of company-specific news. The stock is rising on heavy volume as it trends across social media platforms during Friday’s session.

GSIT has a share float of only 19.564 million, making it a low float stock. The stock has seen a marked 64.21 million shares traded as of Friday at 1:30pm EDT, easily surpassing the trailing 100-day volume of 248,000 shares.

See Also: Who Is Linda Yaccarino? Twitter’s New CEO Has Colorful Past

GSI Technology is a provider of semiconductor memory solutions. The company develops and markets high performance memory products

According to data from Benzinga Pro, GSIT has a 52-week high of $4.28 and a 52-week low of $1.45.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

FDA Approves AstraZeneca Treatment For Advanced Endometrial Cancer

By Shivani Kumaresan
June 17, 6:38 AM
AstraZeneca's breakthrough drug, Imfinzi, combined with chemotherapy, has been officially approved by the FDA to treat advanced forms of endometrial cancer with mismatch repair deficiency. This critical approval is based on Phase III trial results showing a 58% reduction in disease progression, promising improved outcomes for those battling this severe cancer.

AZN